October 2007 — Catalyst Biosciences, located in South San Francisco, California, has opted to use R&D Logic software for time collection efforts, while planning and tracking project resources. Catalyst Biosciences is a leading biotechnology company focused on developing proteases as a therapeutic platform for inflammation, cardiovascular, and angiogenesis-based disorders.

August 2007 — Via Pharmaceuticals, Inc., located in San Francisco, California, has selected R&D Logic enterprise software for financial planning and analysis, consolidated reporting as well as for project time collection and project portfolio specific planning and tracking. VIA is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease.

June 2007 — Kalypsys, Inc., located in San Diego, California, has chosen R&D Logic software for tracking and planning project resources and time effort. Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developing breakthrough therapies for some of the world's most widespread diseases including cardiovascular/metabolic diseases, pain/inflammation and oncology.

December 2006 — Five Príme Therapeutics, Inc., located in San Francisco, California, has selected R&D Logic software for planning and tracking, and time collection. FivePríme Therapeutics, Inc. is a pre-clinical stage biotech company discovering and developing innovative protein and antibody therapeutics. FivePríme is developing treatments for cancer and diabetes and multiple leads in metabolic and immunologic diseases, oncology and regenerative medicine.

November 2006 — Macroflux Corporation, located in Mountain View, California, has opted to use the R&D Logic complete enterprise solution for planning and tracking, and time collection. Macroflux is a spin-out of ALZA Corporation (a subsidiary of Johnson & Johnson). The Macroflux system is based on a small patch and applicator that is intended to provide a needle-free solution for transdermal delivery of therapeutic proteins, peptides and vaccines. It is designed to combine painless and convenient drug administration with rapid delivery and high bioavailability.

October 2006 — SGX Pharmaceuticals Inc., located in San Diego, California, has decided to use R&D Logic enterprise solution to support FP&A company-wide processes. SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.

September 2006 — Alnylam Pharmaceuticals Inc., located in Cambridge, Massachusetts, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and financial planning as well as monthly tracking and analysis. Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi.

August 2006 — Momenta Pharmaceuticals Inc., located in Cambridge, Massachusetts, has selected R&D Logic suite of software to support planning and tracking, time collection and corporate analysis and financial reporting. Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes.

July 2006 — InterMune Inc., located in Brisbane, California, has opted to use R&D Logic software to support Project Time collection as well Time off collecting and tracking, our latest addition to the enterprise solution. In addition, InterMune will be using software capabilities to track and analyze resource utilization by project and program. InterMune is a publicly traded biotech company focused on developing and commercializing innovative therapies in hepatology and pulmonology.

June 2006 — Titan Pharmaceuticals Inc., located in South San Francisco, California, has selected the full R&D Logic suite of software to support corporate planning and tracking, time collection, and financial reporting. Titan is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders.

December 2005 — Valentis, Inc., located in Burlingame, California, has selected R&D Time to replace in-house time and attendance system and complete the R&D Logic enterprise suite that has been in used for the past four years. Valentis is a biotechnology company engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market.

August 2005 — NeuroMolecular Pharmaceuticals, Inc., located in Emeryville, California has selected R&D Manage™ and P&L platform to support project portfolio and corporate planning and tracking business processes. NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders.

August 2005 — Avidia, Inc. located in Mountain View, California, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and operational planning as well as monthly collecting and tracking. Avidia is focused on developing a new class of therapeutic proteins for treatments in areas including autoimmunity, inflammation and oncology.

October 2004 — Avigen, Inc. located in Alameda, California has selected R&D Manage and R&D Time software to support corporate and project planning and tracking activities. Avigen (NASDAQ: AVGN) is a leader in the development of gene therapy products to treat serious, chronic diseases.

January 2004 — Epix, who currently uses R&D Manage for their corporate budgeting and tracking, has decided to expand their usage of R&D Logic products and include R&D Time, a software tool specifically developed to collect project efforts by employee. R&D Time will replace the current time collection system.